Voyager Therapeutics, Inc. Capital Expenditures
Voyager Therapeutics, Inc. (VYGR) reported Capital Expenditures of $14.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $14.00K, a 97.87% decline year-over-year.
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $626.00K, a 303.87% increase year-over-year.
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $207.00K, a 19.77% decline year-over-year.
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $2.60M, a 26.27% decline from fiscal 2024.
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $3.52M, a 8.14% increase from fiscal 2023.
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $3.26M, a 30.71% increase from fiscal 2022.
- Voyager Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $2.49M, a 54.82% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $14.00K 10-Q · filed 2026-08-06 | $640.00K derived: sum of 3 quarters · filed 2026-08-06 | $847.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $14.00K 10-Q · filed 2026-05-07 | $640.00K derived: sum of 2 quarters · filed 2026-05-07 | $847.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $833.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.94M derived: sum of 3 quarters · filed 2026-08-06 | $2.60M 10-K · filed 2026-03-09 |
| 2025-09-30 | $207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.31M derived: sum of 2 quarters · filed 2026-08-06 | $1.97M 10-Q · filed 2025-11-10 | $2.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.76M 10-Q · filed 2026-08-06 | $1.92M derived: sum of 3 quarters · filed 2026-08-06 | $2.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $658.00K 10-Q · filed 2026-05-07 | $813.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.07M derived: sum of 3 quarters · filed 2026-05-07 | $2.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $413.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.38M derived: sum of 3 quarters · filed 2026-03-09 | $3.52M 10-K · filed 2026-03-09 |
| 2024-09-30 | $258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.23M derived: sum of 2 quarters · filed 2025-11-10 | $3.37M 10-Q · filed 2025-11-10 | $4.12M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $967.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.11M 10-Q · filed 2025-08-06 | $3.86M derived: sum of 3 quarters · filed 2026-03-09 | $4.64M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $2.14M 10-Q · filed 2025-05-06 | $2.90M derived: sum of 2 quarters · filed 2026-03-09 | $3.68M derived: sum of 3 quarters · filed 2026-03-09 | $4.89M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $755.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.54M derived: sum of 2 quarters · filed 2026-03-09 | $2.75M derived: sum of 3 quarters · filed 2026-03-09 | $3.26M 10-K · filed 2026-03-09 |
| 2023-09-30 | $782.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.99M derived: sum of 2 quarters · filed 2024-11-12 | $2.50M 10-Q · filed 2024-11-12 | $3.43M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.72M 10-Q · filed 2024-08-06 | $2.65M derived: sum of 3 quarters · filed 2025-03-11 | $2.93M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $509.00K 10-Q · filed 2024-05-13 | $1.44M derived: sum of 2 quarters · filed 2025-03-11 | $1.72M derived: sum of 3 quarters · filed 2025-03-11 | $2.96M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.21M derived: sum of 2 quarters · filed 2025-03-11 | $2.45M derived: sum of 3 quarters · filed 2025-03-11 | $2.49M 10-K · filed 2025-03-11 |
| 2022-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.52M derived: sum of 2 quarters · filed 2023-11-06 | $1.56M 10-Q · filed 2023-11-06 | $1.91M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.28M 10-Q · filed 2023-08-03 | $1.63M derived: sum of 3 quarters · filed 2024-02-28 | $2.29M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $38.00K 10-Q · filed 2023-05-09 | $385.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.04M derived: sum of 3 quarters · filed 2024-02-28 | $1.27M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $347.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.01M derived: sum of 2 quarters · filed 2024-02-28 | $1.23M derived: sum of 3 quarters · filed 2024-02-28 | $1.61M 10-K · filed 2024-02-28 |
| 2021-09-30 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $887.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.26M 10-Q · filed 2022-11-08 | $4.82M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $602.00K 10-Q · filed 2022-08-04 | $4.16M derived: sum of 3 quarters · filed 2023-03-07 | $9.31M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $375.00K 10-Q · filed 2022-05-04 | $3.93M derived: sum of 2 quarters · filed 2023-03-07 | $9.08M derived: sum of 3 quarters · filed 2023-03-07 | $10.96M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $8.71M derived: sum of 2 quarters · filed 2023-03-07 | $10.59M derived: sum of 3 quarters · filed 2023-03-07 | $12.10M 10-K · filed 2023-03-07 |
| 2020-09-30 | $5.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $7.03M derived: sum of 2 quarters · filed 2021-11-02 | $8.54M 10-Q · filed 2021-11-02 | $11.92M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $3.39M 10-Q · filed 2021-08-09 | $6.76M derived: sum of 3 quarters · filed 2022-03-08 | $7.94M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $1.51M 10-Q · filed 2021-05-10 | $4.88M derived: sum of 2 quarters · filed 2022-03-08 | $6.06M derived: sum of 3 quarters · filed 2022-03-08 | $8.12M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $4.55M derived: sum of 2 quarters · filed 2022-03-08 | $6.61M derived: sum of 3 quarters · filed 2022-03-08 | $7.72M 10-K · filed 2022-03-08 |
| 2019-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.24M derived: sum of 2 quarters · filed 2020-11-09 | $4.34M 10-Q · filed 2020-11-09 | $4.87M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.17M 10-Q · filed 2020-08-10 | $3.69M derived: sum of 3 quarters · filed 2021-02-25 | $4.54M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $1.10M 10-Q · filed 2020-05-06 | $1.63M derived: sum of 2 quarters · filed 2021-02-25 | $2.48M derived: sum of 3 quarters · filed 2021-02-25 | $3.80M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.37M derived: sum of 2 quarters · filed 2021-02-25 | $2.70M derived: sum of 3 quarters · filed 2021-02-25 | $4.30M 10-K · filed 2021-02-25 |
| 2018-09-30 | $849.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $2.17M derived: sum of 2 quarters · filed 2019-11-06 | $3.78M 10-Q · filed 2019-11-06 | $3.94M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.93M 10-Q · filed 2019-08-09 | $3.09M derived: sum of 3 quarters · filed 2020-03-03 | $3.51M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $1.61M 10-Q · filed 2019-05-07 | $1.77M derived: sum of 2 quarters · filed 2020-03-03 | $2.18M derived: sum of 3 quarters · filed 2020-03-03 | $2.65M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $573.00K derived: sum of 2 quarters · filed 2020-03-03 | $1.04M derived: sum of 3 quarters · filed 2020-03-03 | $3.98M 10-K · filed 2020-03-03 |
| 2017-09-30 | $412.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $879.00K derived: sum of 2 quarters · filed 2018-11-07 | $3.82M 10-Q · filed 2018-11-07 | $7.69M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.41M 10-Q · filed 2018-08-07 | $7.28M derived: sum of 3 quarters · filed 2019-02-26 | $7.78M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $2.94M 10-Q · filed 2018-05-10 | $6.81M derived: sum of 2 quarters · filed 2019-02-26 | $7.32M derived: sum of 3 quarters · filed 2019-02-26 | $7.51M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $4.37M derived: sum of 2 quarters · filed 2019-02-26 | $4.57M derived: sum of 3 quarters · filed 2019-02-26 | $5.03M 10-K · filed 2019-02-26 |
| 2016-09-30 | $503.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $700.00K derived: sum of 2 quarters · filed 2017-11-02 | $1.16M 10-Q · filed 2017-11-02 | $1.28M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $657.00K 10-Q · filed 2017-08-08 | $778.00K derived: sum of 3 quarters · filed 2018-03-14 | $1.04M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $460.00K 10-Q · filed 2017-05-09 | $581.00K derived: sum of 2 quarters · filed 2018-03-14 | $840.00K derived: sum of 3 quarters · filed 2018-03-14 | $1.34M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $380.00K derived: sum of 2 quarters · filed 2018-03-14 | $880.00K derived: sum of 3 quarters · filed 2018-03-14 | $1.03M 10-K · filed 2018-03-14 |
| 2015-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $759.00K derived: sum of 2 quarters · filed 2016-11-10 | $909.00K 10-Q · filed 2016-11-10 | $1.92M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $650.00K 10-Q · filed 2016-08-11 | $1.66M derived: sum of 3 quarters · filed 2017-03-15 | |
| 2015-03-31 | $150.00K 10-Q · filed 2016-05-12 | $1.16M derived: sum of 2 quarters · filed 2017-03-15 | ||
| 2014-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.99M 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $1.98M 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |